Protein-peptide docking: opportunities and challenges

Drug Discov Today. 2018 Aug;23(8):1530-1537. doi: 10.1016/j.drudis.2018.05.006. Epub 2018 May 4.

Abstract

Peptides have recently attracted much attention as promising drug candidates. Rational design of peptide-derived therapeutics usually requires structural characterization of the underlying protein-peptide interaction. Given that experimental characterization can be difficult, reliable computational tools are needed. In recent years, a variety of approaches have been developed for 'protein-peptide docking', that is, predicting the structure of the protein-peptide complex, starting from the protein structure and the peptide sequence, including variable degrees of information about the peptide binding site and/or conformation. In this review, we provide an overview of protein-peptide docking methods and outline their capabilities, limitations, and applications in structure-based drug design. Key challenges are also briefly discussed, such as modeling of large-scale conformational changes upon binding, scoring of predicted models, and optimal inclusion of varied types of experimental data and theoretical predictions into an integrative modeling process.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Binding Sites
  • Drug Design*
  • Humans
  • Molecular Docking Simulation*
  • Peptides / chemical synthesis
  • Peptides / pharmacology*
  • Protein Binding
  • Protein Conformation
  • Structure-Activity Relationship

Substances

  • Peptides